WallStreetZenWallStreetZen

NASDAQ: SNOA
Sonoma Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Sonoma Pharmaceuticals earnings were -$2.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SNOA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$330.0k, down 43.2% from last quarter. For the last reported fiscal year 2026 ending Mar 31, 2026, SNOA reported annual earnings of -$3.2M, with -8.2% growth.

SNOA earnings history

Current Revenue
$21.9M
Current Earnings
-$2.3M
Current Profit Margin
-10.3%

SNOA Return on Equity

Current Company
-53.6%
Current Industry
-1.8%
Current Market
28.7%
SNOA's Return on Equity (-53.6%)... subscribe to Premium to read more.
High Return on Equity Performance

SNOA Return on Assets

Current Company
-15.2%
Current Industry
3.3%
SNOA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SNOA announces earnings.

SNOA Return on Capital Employed

Current Company
-19.8%
Current Industry
8.7%
SNOA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SNOA vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SNOA-$2.37M-$2.26MN/A-$1.22
GELSN/A-$4.95MN/A-$0.49
YCBD-$951.19k-$3.11MN/A$0.14
APUS-$39.53M-$40.66MN/A-$27.40
AKAN-$46.14M-$45.65MN/A-$662.22
View Top Pharmaceutical Stocks

Sonoma Pharmaceuticals Earnings Reports & History FAQ

What were Sonoma Pharmaceuticals's earnings last quarter?

On SNOA's earnings call on Aug 6, 2026, Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q2 2026 earnings per share (EPS) of -$0.09, up 88.16% year over year. Total SNOA earnings for the quarter were -$330.00 thousand. In the same quarter last year, Sonoma Pharmaceuticals's earnings per share (EPS) was -$0.76.

If you're new to stock investing, here's how to buy Sonoma Pharmaceuticals stock.

Is Sonoma Pharmaceuticals profitable or losing money?

As of the last Sonoma Pharmaceuticals earnings report, Sonoma Pharmaceuticals is currently losing money. Sonoma Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$2.26 million, a 36.32% decrease year over year.

What was SNOA's earnings growth in the past year?

As of Sonoma Pharmaceuticals's earnings date in Aug 6, 2026, Sonoma Pharmaceuticals's earnings has grown year over year. SNOA earnings in the past year totalled -$2.26 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.